What is Alexander's's earnings per share (EPS)?

Alexander's (ALX) reported diluted earnings per share of $5.50 for fiscal year 2025. This represents a -35.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Alexander's Financials

ALX

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Alexander's (ALX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ALX FY2025 2026-05-04

Financing and distributions are shaping Alexander's economics more than the relatively steady revenue base.

Two straight years of outsized payouts help explain why cash fell to $128.2M and debt-to-equity reached 9.2x even though the top line stayed in the same general range. Because the dividend stayed near $92.4M while profit shrank, the balance sheet rather than the income statement absorbed the pressure, leaving a much thinner equity cushion.

Cash conversion looked better than accounting profit: operating cash flow was $73.4M versus net income of $28.2M. Heavy depreciation on a large asset base means the properties generated more cash than earnings alone suggest, but still not enough to fully self-fund the distribution.

With SG&A only about 3.1% of revenue while interest expense ran $51.6M, the cost base appears finance-heavy rather than overhead-heavy. That makes shareholder earnings unusually sensitive to capital structure and financing costs, which helps explain why margins swing far more than sales.

Financial Health Signals

Financial Profile 17/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Alexander's's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth

Alexander's's revenue declined 5.8% year-over-year, from $226.4M to $213.2M. This contraction results in a growth score of 29/100.

Leverage

Alexander's has elevated debt relative to equity (D/E of 9.18), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.

Returns

Alexander's earns a strong 25.9% return on equity (ROE), meaning it generates $26 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 75/100. This is up from 24.6% the prior year.

Piotroski F-Score Neutral

5/9

Alexander's passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

2.60x

For every $1 of reported earnings, Alexander's generates $2.60 in operating cash flow ($73.4M OCF vs $28.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$213.2M

YoY-5.8%

5Y CAGR+1.4%

Alexander's generated $213.2M in revenue in fiscal year 2025. This represents a decrease of 5.8% from the prior year.

EBITDA

N/A

Net Income

$28.2M

YoY-35.0%

5Y CAGR-7.6%

10Y CAGR-9.5%

Alexander's reported $28.2M in net income in fiscal year 2025. This represents a decrease of 35.0% from the prior year.

EPS (Diluted)

$5.50

YoY-35.0%

5Y CAGR-7.7%

Alexander's earned $5.50 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 35.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$128.2M

YoY-62.1%

5Y CAGR-21.5%

10Y CAGR-6.8%

Alexander's held $128.2M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

$18.00

YoY+0.0%

5Y CAGR+0.0%

Alexander's paid $18.00 per share in dividends in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Shares Outstanding

YoY+0.0%

5Y CAGR+0.0%

10Y CAGR+0.0%

Alexander's had 5M shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

13.2%

YoY-5.9pp

5Y CAGR-7.8pp

Alexander's's net profit margin was 13.2% in fiscal year 2025, showing the share of revenue converted to profit. This is down 5.9 percentage points from the prior year.

Return on Equity

25.9%

YoY+1.3pp

5Y CAGR+5.2pp

10Y CAGR+4.1pp

Alexander's's ROE was 25.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 1.3 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

ALX Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$213.2M-5.8%	$226.4M+0.6%	$225.0M+9.3%	$205.8M-0.2%	$206.1M+3.5%	$199.1M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$6.6M+0.6%	$6.5M+2.8%	$6.3M+3.8%	$6.1M+3.1%	$5.9M-6.1%	$6.3M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$51.6M-17.8%	$62.8M+7.8%	$58.3M+103.8%	$28.6M+45.3%	$19.7M-18.7%	$24.2M
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	$28.2M-35.0%	$43.4M-57.6%	$102.4M+77.7%	$57.6M-56.6%	$132.9M+217.0%	$41.9M
EPS (Diluted)	$5.50-35.0%	$8.46-57.6%	$19.97+77.7%	$11.24-56.7%	$25.94+216.7%	$8.19

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$53.4M+0.3%	$53.3M-0.3%	$53.4M+3.6%	$51.6M-6.1%	$54.9M-1.8%	$55.9M+0.4%	$55.7M+4.3%	$53.4M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$1.7M+3.2%	$1.7M+23.1%	$1.3M-31.0%	$2.0M+22.9%	$1.6M+8.9%	$1.5M+2.7%	$1.4M-34.1%	$2.2M
Operating Income	$24.4M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$10.7M-23.1%	$14.0M-0.9%	$14.1M+10.0%	$12.8M+18.6%	$10.8M-2.8%	$11.1M-42.3%	$19.3M+18.8%	$16.2M
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	$4.7M+21.9%	$3.8M-35.9%	$6.0M-2.5%	$6.1M-50.3%	$12.3M+0.3%	$12.3M+83.8%	$6.7M-20.3%	$8.4M
EPS (Diluted)	$0.91	N/A	$1.16-2.5%	$1.19-50.4%	$2.40	N/A	$1.30-20.2%	$1.63

ALX Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$1.1B-17.2%	$1.3B-4.4%	$1.4B+0.4%	$1.4B+0.4%	$1.4B-0.9%	$1.4B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$128.2M-62.1%	$338.5M-36.3%	$531.9M+172.8%	$194.9M-57.9%	$463.5M+8.1%	$428.7M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$4.1M-19.6%	$5.1M-15.9%	$6.1M+29.1%	$4.7M-26.3%	$6.4M-21.3%	$8.1M
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$1.0B-14.0%	$1.2B-0.1%	$1.2B+0.4%	$1.2B+1.9%	$1.1B-5.1%	$1.2B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$109.2M-38.3%	$176.9M-25.6%	$237.7M+0.5%	$236.5M-6.4%	$252.6M+24.3%	$203.2M
Retained Earnings	$69.2M-48.1%	$133.4M-26.8%	$182.3M+5.9%	$172.2M-16.7%	$206.9M+24.5%	$166.2M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$1.1B-1.3%	$1.1B-14.3%	$1.3B-1.9%	$1.3B-0.9%	$1.3B-0.6%	$1.3B-1.7%	$1.4B-7.8%	$1.5B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$76.2M-40.5%	$128.2M-55.2%	$286.1M-8.6%	$313.0M-2.1%	$319.9M-5.5%	$338.5M-4.6%	$354.8M-13.7%	$410.9M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$2.5M-38.6%	$4.1M-5.3%	$4.3M+5.0%	$4.1M-22.9%	$5.4M+4.9%	$5.1M+7.7%	$4.7M+3.2%	$4.6M
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$1.0B+0.4%	$1.0B-14.2%	$1.2B-0.6%	$1.2B+0.5%	$1.2B+0.5%	$1.2B-0.8%	$1.2B-7.4%	$1.3B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$748K	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$90.7M-16.9%	$109.2M-14.9%	$128.3M-11.8%	$145.4M-10.8%	$163.1M-7.8%	$176.9M-7.3%	$190.7M-10.3%	$212.5M
Retained Earnings	$50.8M-26.7%	$69.2M-21.8%	$88.5M-16.2%	$105.6M-13.8%	$122.6M-8.1%	$133.4M-7.5%	$144.2M-10.2%	$160.6M

ALX Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$73.4M+35.7%	$54.1M-50.4%	$109.1M+6.4%	$102.5M-13.4%	$118.5M+51.7%	$78.1M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$20.8M-57.2%	-$13.2M-104.1%	$321.8M+215.2%	-$279.3M-470.1%	$75.5M+332.5%	-$32.5M
Financing Cash Flow	-$254.3M-27.1%	-$200.0M-116.4%	-$92.4M-0.1%	-$92.3M+42.4%	-$160.3M-277.5%	$90.3M
Dividends Paid	$92.4M+0.1%	$92.4M+0.1%	$92.3M+0.1%	$92.3M0.0%	$92.2M+0.1%	$92.2M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	$6.8M-70.9%	$23.4M+352.8%	-$9.3M-121.3%	$43.6M+177.1%	$15.7M-49.0%	$30.8M+712.4%	-$5.0M-143.7%	$11.5M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$23.9M-1225.8%	-$1.8M+58.6%	-$4.4M+34.2%	-$6.6M+17.6%	-$8.0M+19.4%	-$9.9M-172.3%	-$3.7M-1102.0%	-$304K
Financing Cash Flow	-$23.1M+87.3%	-$181.7M-643.7%	-$24.4M-0.5%	-$24.3M-1.7%	-$23.9M+1.3%	-$24.2M+79.6%	-$118.5M-246.3%	-$34.2M
Dividends Paid	$23.1M0.0%	$23.1M0.0%	$23.1M0.0%	$23.1M0.0%	$23.1M0.0%	$23.1M0.0%	$23.1M+0.1%	$23.1M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

ALX Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	13.2%-5.9pp	19.2%-26.3pp	45.5%+17.5pp	28.0%-36.5pp	64.5%+43.4pp	21.1%
Return on Equity	25.9%+1.3pp	24.6%-18.5pp	43.1%+18.7pp	24.4%-28.3pp	52.6%+32.0pp	20.6%
Return on Assets	2.5%-0.7pp	3.2%-4.1pp	7.3%+3.2pp	4.1%-5.4pp	9.6%+6.6pp	3.0%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	9.18+2.6	6.58+1.7	4.910.0	4.91+0.4	4.51-1.4	5.91
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	45.7%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	8.7%+1.6pp	7.2%-4.0pp	11.2%-0.7pp	11.9%-10.6pp	22.4%+0.5pp	22.0%+10.0pp	12.0%-3.7pp	15.7%
Return on Equity	5.1%+1.6pp	3.5%-1.1pp	4.7%+0.4pp	4.2%-3.3pp	7.5%+0.6pp	6.9%+3.4pp	3.5%-0.4pp	3.9%
Return on Assets	0.4%+0.1pp	0.3%-0.1pp	0.5%0.0pp	0.5%-0.5pp	0.9%0.0pp	0.9%+0.4pp	0.5%-0.1pp	0.6%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	11.08+1.9	9.18+0.1	9.10+1.0	8.08+0.9	7.17+0.6	6.58+0.4	6.16+0.2	5.97
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Alexander & Baldwin Inc ALEX

$1.5B

Saul Ctrs Inc BFS

$852.1M

Cbl & Assoc Pptys Inc CBL

$1.5B

Getty Rlty Corp GTY

$2.0B

Netstreit Corp NTST

$2.0B

Frequently Asked Questions

What is Alexander's's annual revenue?

Alexander's (ALX) reported $213.2M in total revenue for fiscal year 2025. This represents a -5.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Alexander's's revenue growing?

Alexander's (ALX) revenue declined by 5.8% year-over-year, from $226.4M to $213.2M in fiscal year 2025.

Is Alexander's profitable?

Yes, Alexander's (ALX) reported a net income of $28.2M in fiscal year 2025, with a net profit margin of 13.2%.

What is Alexander's's net profit margin?

Alexander's (ALX) had a net profit margin of 13.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Alexander's pay dividends?

Yes, Alexander's (ALX) paid $18.00 per share in dividends during fiscal year 2025.

What is Alexander's's return on equity (ROE)?

Alexander's (ALX) has a return on equity of 25.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Alexander's's operating cash flow?

Alexander's (ALX) generated $73.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Alexander's's total assets?

Alexander's (ALX) had $1.1B in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Alexander's have outstanding?

Alexander's (ALX) had 5M shares outstanding as of fiscal year 2025.

What is Alexander's's debt-to-equity ratio?

Alexander's (ALX) had a debt-to-equity ratio of 9.18 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Alexander's's return on assets (ROA)?

Alexander's (ALX) had a return on assets of 2.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Alexander's's Piotroski F-Score?

Alexander's (ALX) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Alexander's's earnings high quality?

Alexander's (ALX) has an earnings quality ratio of 2.60x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Alexander's?

Alexander's (ALX) scores 17 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.